West Pharmaceutical Services, Inc. (WST)

US — Healthcare Sector
Peers: TFX  ALC  RMD  ICUI  COO  HOLX  HAE  BDX  RGEN  EMBC  BAX  MMSI 

Automate Your Wheel Strategy on WST

With Tiblio's Option Bot, you can configure your own wheel strategy including WST - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol WST
  • Rev/Share 39.9407
  • Book/Share 37.0083
  • PB 5.6868
  • Debt/Equity 0.113
  • CurrentRatio 2.7672
  • ROIC 0.1441

 

  • MktCap 15120582884.0
  • FreeCF/Share 4.2331
  • PFCF 49.2688
  • PE 32.6591
  • Debt/Assets 0.0838
  • DivYield 0.0039
  • ROE 0.1747

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 3
  • P/B Score 1
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation WST Evercore ISI -- Outperform -- $275 March 18, 2025
Upgrade WST Deutsche Bank Hold Buy -- $250 Feb. 14, 2025
Initiation WST Citigroup -- Buy -- $400 Jan. 8, 2025
Initiation WST Wolfe Research -- Peer Perform -- -- Dec. 13, 2024
Upgrade WST UBS Neutral Buy $350 $390 Dec. 12, 2024

News

Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?
WST
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive

The average of price targets set by Wall Street analysts indicates a potential upside of 31.1% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Read More
image for news Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?
July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
WST
Published: May 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149160&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

Read More
image for news July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025
WST
Published: May 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149144&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

Read More
image for news Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
WST
Published: May 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

Read More
image for news WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
WST
Published: May 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149117&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
WST
Published: May 19, 2025 by: PRNewsWire
Sentiment: Neutral

SAN DIEGO , May 19, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, all dates inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v.

Read More
image for news WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today
WST
Published: May 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149110&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
WST
Published: May 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149084&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
WST
Published: May 18, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 18, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

Read More
image for news WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
WST
Published: May 18, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 18, 2025 /PRNewswire/ -- Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

Read More
image for news WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline
WST
Published: May 17, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 17, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149000&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

Read More
image for news WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline
ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
WST
Published: May 17, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025.

Read More
image for news ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
WST
Published: May 16, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.

Read More
image for news Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
WST
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148915&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025
WST
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148907&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

Read More
image for news Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
WST
Published: May 16, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 7, 2025.

Read More
image for news WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders
WST
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148812&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

Read More
image for news Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
WST
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148797&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

Read More
image for news Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
WST
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

Read More
image for news WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
WST
Published: May 16, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.

Read More
image for news Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST
WST
Published: May 15, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST).

Read More
image for news Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline
WST
Published: May 15, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148717&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline
Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
WST
Published: May 15, 2025 by: Business Wire
Sentiment: Neutral

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFFICES OF HOWARD G. S.

Read More
image for news Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
WST
Published: May 14, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action.

Read More
image for news Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline
WST
Published: May 14, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148471&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
WST
Published: May 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.

Read More
image for news Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
Rosen Law Firm Urges West Pharmaceutical Services, Inc. (NYSE: WST) Stockholders to Contact the Firm for Information About Their Rights
WST
Published: May 13, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025. West describes itself as a “medical supplies company specializing in packaging components, containment solutions, and delivery systems for injectable drugs.” For more information, submit a form, email attorney Phillip Kim, or give u.

Read More
image for news Rosen Law Firm Urges West Pharmaceutical Services, Inc. (NYSE: WST) Stockholders to Contact the Firm for Information About Their Rights
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
WST
Published: May 13, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). West investors have until July 7, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LO.

Read More
image for news Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
WST
Published: May 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148258&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
WST
Published: May 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148258&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST

About West Pharmaceutical Services, Inc. (WST)

  • IPO Date 1980-03-17
  • Website https://www.westpharma.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Eric M. Green
  • Employees 10600

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.